Staublein

Staublein v. Acadia Pharmaceuticals Inc.

Good Law
United States District Court, Southern District of CaliforniaJuly 16, 20203:18-cv-01647California544 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 7 Case No.: 18-cv-01647-AJB-BGS

IN RE ACADIA PHARMACEUTICALS ORDER VACATING AUGUST 19,

INC. SECURITIES LITIGATION 2020 EARLY NEUTRAL

EVALUATION CONFERENCE,

CASE MANAGEMENT

CONFERENCE, & RELATED

DATES

14 [ECF NO. 75]

16 On July 15, 2020, the parties filed a Joint Motion to Withdraw Notice and Order for 17 Early Neutral Evaluation (“ENE”) Conference. (ECF No. 75.) The parties indicate that 18 Plaintiff will file his Second Amended Complaint by July 16, 2020 and that Defendants 19 will subsequently file a Motion to Dismiss the Second Amended Complaint. (Id. at 2.) 20 The parties request the Court to withdraw its ENE Order (ECF No. 68) and vacate all 21 associated deadlines, including taking the August 19, 2020 ENE Conference off calendar. 22 (ECF No. 75 at 2.) 23 The parties’ request is based on the mandatory stay of discovery implemented by the 24 Private Securities Litigation Reform Act (“PSLRA”). (Id.) The PSLRA requires “all 25 discovery and…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.